A cure for cancer, Alzheimer’s, depression? FDA smacks down wild CBD claims

Enlarge / Curaleaf products. (credit: Curaleaf)

One CBD company sure has been busy.

The company Curaleaf claims that it has developed products that can treat a slew of the most formidable conditions found in humans, including cancer, Alzheimer's, Parkinson's, depression, opioid withdrawal, chronic pain, anxiety, post-traumatic stress disorder (PTSD), and attention deficit/hyperactivity disorder (ADHD). It also has products said to treat anxiety, pain, and diabetes in cats and dogs. (The product comes in bacon and salmon flavors.) And just one ingredient in all of its products is responsible for these remarkable medical breakthroughs: the cannabis-derived compound cannabidiol (CBD).

Sadly, those claims are not backed by evidence.

Read 9 remaining paragraphs | Comments